2 studies found for:    22356324 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Study of Neoadjuvant Vemurafenib for BRAF Mutant Melanoma and Palpable Lymph Node Metastasis
Condition: Melanoma
Intervention: Drug: Vemurafenib
2 Active, not recruiting
Has Results
A Study of Vemurafenib in Previously Treated Patients With Metastatic Melanoma
Condition: Malignant Melanoma
Intervention: Drug: vemurafenib

Indicates status has not been verified in more than two years